رجوع
34
1
مُدرج أيضًا باسم
MAHLY
OTC
نطاق اليوم
KWD 19.00
KWD 19.00
نطاق 52 أسبوعًا
KWD 14.75
KWD 19.00
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 18.50
/
KWD 16.78
الإغلاق السابق
KWD 19.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 6.6 | 3.7 |
| Net Margin % | 1.1 | 3.8 |
| Rev Growth 5Y % | 3.4 | 10.0 |
| D/E | 0.0 | 0.2 |
النقاط الرئيسية
Revenue grew 3.40% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Generating 48.13B in free cash flow
P/E of 0.10 — trading at a low valuation
Cash machine — converts 119.49% of earnings into free cash flow
Capital efficient — spends only 0.34% of revenue on capex
النمو
Revenue Growth (5Y)
3.40%
Revenue (1Y)3.16%
Earnings (1Y)-2.88%
FCF Growth (3Y)326.81%
الجودة
Return on Equity
6.60%
ROIC6.73%
Net Margin1.10%
Op. Margin1.51%
الأمان
Debt / Equity
0.00
Current Ratio1.27
Interest Coverage7944.14
التقييم
P/E Ratio
0.10
P/B Ratio0.01
EV/EBITDA-4.63
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.16% | Revenue Growth (3Y) | 4.53% |
| Earnings Growth (1Y) | -2.88% | Earnings Growth (3Y) | 1.88% |
| Revenue Growth (5Y) | 3.40% | Earnings Growth (5Y) | 13.91% |
| Profitability | |||
| Revenue (TTM) | 3.67T | Net Income (TTM) | 40.28B |
| ROE | 6.60% | ROA | 2.21% |
| Gross Margin | 6.97% | Operating Margin | 1.51% |
| Net Margin | 1.10% | Free Cash Flow (TTM) | 48.13B |
| ROIC | 6.73% | FCF Growth (3Y) | 326.81% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.27 |
| Interest Coverage | 7944.14 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.10 | P/B Ratio | 0.01 |
| P/S Ratio | 0.00 | PEG Ratio | -9.71 |
| EV/EBITDA | -4.63 | Dividend Yield | 0.02% |
| Market Cap | 3.89B | Enterprise Value | -257.52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.67T | 3.56T | 3.36T | 3.29T | 3.21T |
| Net Income | 40.28B | 41.47B | 38.81B | 29.42B | 23.93B |
| EPS (Diluted) | 193.20 | 195.83 | 179.12 | 131.41 | 106.80 |
| Gross Profit | 255.76B | 246.66B | 224.31B | 217.45B | 214.26B |
| Operating Income | 55.61B | 47.33B | 48.97B | 45.62B | 38.58B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.82T | 1.80T | 1.70T | 1.71T | 1.68T |
| Total Liabilities | 1.07T | 1.06T | 1.02T | 1.06T | 1.04T |
| Shareholders' Equity | 619.56B | 600.35B | 561.36B | 530.30B | 523.01B |
| Total Debt | 0.0 | 1.46B | 7.38B | 30.08B | 30.58B |
| Cash & Equivalents | 261.41B | 230.15B | 195.03B | 243.15B | 222.75B |
| Current Assets | 1.28T | 1.24T | 1.18T | 1.21T | 1.17T |
| Current Liabilities | 1.01T | 1.01T | 971.52B | 1.01T | 952.84B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#580 of 820
#691 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026